Retention Period of Amyloid ß1-42 in the Brain Extracellular Fluid as the Toxicological Determinant in Freely Moving Rats.

The pathological significance of amyloid-ß1-42 (Aß1-42) dynamics is poorly understood in the brain extracellular compartment. Here we test which of the concentration or the retention is critical for Aß1-42 toxicity after injection of equal dose into dentate granule cell layer of freely moving rats. The toxicity of Aß1-42 (25 µM) was compared between injections at the rate of 0.25 µL/min for 4 min (fast injection) and 0.025 µL/min for 40 min (slow injection). Dentate gyrus long-term potentiation (LTP) was affected 1 and 2 h after the fast injection, but not 4 h. In contrast, LTP was affected even 72 h after the slow injection. Aß1-42 staining 5 min after finish of the slow injection was more intense in the dentate granule cell layer than of the fast injection. The present study indicates that the retention of Aß1-42 in the extracellular fluid is correlated with neuronal Aß1-42 uptake and plays a key role in Aß1-42 neurotoxicity. In the extracellular fluid of the dentate gyrus, the retention period of Aß1-42 is much more critical for Aß1-42 toxicity than Aß1-42 concentration. It is likely that Aß1-42 toxicity is accelerated by the disturbance of Aß1-42 metabolism in the dentate gyrus.

Extracellular Zn2+ Is Essential for Amyloid ß1-42-Induced Cognitive Decline in the Normal Brain and Its Rescue.

Brain Aß1-42 accumulation is considered an upstream event in pathogenesis of Alzheimer's disease. However, accumulating evidence indicates that other neurochemical changes potentiate the toxicity of this constitutively generated peptide. Here we report that the interaction of Aß1-42 with extracellular Zn2+ is essential for in vivo rapid uptake of Aß1-42 and Zn2+ into dentate granule cells in the normal rat hippocampus. The uptake of both Aß1-42 and Zn2+ was blocked by CaEDTA, an extracellular Zn2+ chelator, and by Cd2+, a metal that displaces Zn2+ for Aß1-42 binding. In vivo perforant pathway LTP was unaffected by perfusion with 1000 nm Aß1-42 in ACSF without Zn2+ However, LTP was attenuated under preperfusion with 5 nm Aß1-42 in ACSF containing 10 nm Zn2+, recapitulating the concentration of extracellular Zn2+, but not with 5 nm Aß1-40 in ACSF containing 10 nm Zn2+ Aß1-40 and Zn2+ were not taken up into dentate granule cells under these conditions, consistent with lower affinity of Aß1-40 for Zn2+ than Aß1-42 Aß1-42-induced attenuation of LTP was rescued by both CaEDTA and CdCl2, and was observed even with 500 pm Aß1-42 Aß1-42 injected into the dentate granule cell layer of rats induced a rapid memory disturbance that was also rescued by coinjection of CdCl2 The present study supports blocking the formation of Zn-Aß1-42 in the extracellular compartment as an effective preventive strategy for Alzheimer's disease.SIGNIFICANCE STATEMENT Short-term memory loss occurs in normal elderly and increases in the predementia stage of Alzheimer's disease (AD). Amyloid-ß1-42 (Aß1-42), a possible causing peptide in AD, is bound to Zn2+ in the extracellular compartment in the hippocampus induced short-term memory loss in the normal rat brain, suggesting that extracellular Zn2+ is essential for Aß1-42-induced short-term memory loss. The evidence is important to find an effective preventive strategy for AD, which is blocking the formation of Zn-Aß1-42 in the extracellular compartment.

Novel Defense by Metallothionein Induction Against Cognitive Decline: From Amyloid ß1-42-Induced Excess Zn2+ to Functional Zn2+ Deficiency.

The role of metallothioneins (MTs) in cognitive decline associated with intracellular Zn2+ dysregulation remains unclear. Here, we report that hippocampal MT induction defends cognitive decline, which was induced by amyloid ß1-42 (Aß1-42)-mediated excess Zn2+ and functional Zn2+ deficiency. Excess increase in intracellular Zn2+, which was induced by local injection of Aß1-42 into the dentate granule cell layer, attenuated in vivo perforant pathway LTP, while the attenuation was rescued by preinjection of MT inducers into the same region. Intraperitoneal injection of dexamethasone, which increased hippocampal MT proteins and blocked Aß1-42-mediated Zn2+ uptake, but not Aß1-42 uptake, into dentate granule cells, also rescued Aß1-42-induced impairment of memory via attenuated LTP. The present study indicates that hippocampal MT induction blocks rapid excess increase in intracellular Zn2+ in dentate granule cells, which originates in Zn2+ released from Aß1-42, followed by rescuing Aß1-42-induced cognitive decline. Furthermore, LTP was vulnerable to Aß1-42 in the aged dentate gyrus, consistent with enhanced Aß1-42-mediated Zn2+ uptake into aged dentate granule cells, suggesting that Aß1-42-induced cognitive decline, which is caused by excess intracellular Zn2+, can more frequently occur along with aging. On the other hand, attenuated LTP under functional Zn2+ deficiency in dentate granule cells was also rescued by MT induction. Hippocampal MT induction may rescue cognitive decline under lack of cellular transient changes in functional Zn2+ concentration, while its induction is an attractive defense strategy against Aß1-42-induced cognitive decline.